Research Paper Volume 10, Issue 9 pp 2356—2366

A seven-long noncoding RNA signature predicts overall survival for patients with early stage non-small cell lung cancer

Figure 1. The seven-lncRNA signature-based risk score in prognosis of overall survival in the discovery group. (A) The seven lncRNA-based risk score distribution. (B) The heatmap of the seven lncRNA expression profiles. (C) The vital status of patients in high- and low-risk groups. (D) The mortality rate in low- and high-risk score groups.